095700.KQ
Genexine, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 3,260.00
+15.81%Margins
Gross margin
-62.7%
EBITDA margin
9.4%
EBIT margin
-786.9%
Net margin
-645.9%
FCF margin
-819.9%
-16.0%
Return on equity
-9.7%
Return on assets
-12.4%
Return on invested capital
0.01x
Asset turnover
-KRW 28.1B
Cash from operations
KRW 569
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026